Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Malmberg

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Bioorganic & Medicinal Chemistry Letters|September 23, 2008
Synthesis and activity of substituted carbamates as potentiators of the alpha4beta2 nicotinic acetylcholine receptorStephanie K Springer, Katrina S Woodin, Virginia Berry, et al.
Bioorganic & Medicinal Chemistry Letters|January 3, 2012
Discovery and optimization of aminopyrimidinones as potent and state-dependent Nav1.7 antagonistsHanh Nho Nguyen, Howie Bregman, John L Buchanan, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 2, 2007
Pharmacological, pharmacokinetic, and primate analgesic efficacy profile of the novel bradykinin B1 Receptor antagonist ELN441958Jon E Hawkinson, Balazs G Szoke, Albert W Garofalo, et al.
Pain|February 20, 2010
Pharmacological effects of nonselective and subtype-selective nicotinic acetylcholine receptor agonists in animal models of persistent painBaoXi Gao, Markus Hierl, Kristie Clarkin, et al.
Molecular Therapy. Nucleic Acids|April 21, 2025
Splicing correction by peptide-conjugated morpholinos as a novel treatment for late-onset Pompe diseaseRyan A Oliver, Meghan E Ahern, Perla G Castaneda, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Bioorganic & Medicinal Chemistry Letters|September 23, 2008
Synthesis and activity of substituted carbamates as potentiators of the alpha4beta2 nicotinic acetylcholine receptorStephanie K Springer, Katrina S Woodin, Virginia Berry, et al.
Bioorganic & Medicinal Chemistry Letters|January 3, 2012
Discovery and optimization of aminopyrimidinones as potent and state-dependent Nav1.7 antagonistsHanh Nho Nguyen, Howie Bregman, John L Buchanan, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 2, 2007
Pharmacological, pharmacokinetic, and primate analgesic efficacy profile of the novel bradykinin B1 Receptor antagonist ELN441958Jon E Hawkinson, Balazs G Szoke, Albert W Garofalo, et al.
Pain|February 20, 2010
Pharmacological effects of nonselective and subtype-selective nicotinic acetylcholine receptor agonists in animal models of persistent painBaoXi Gao, Markus Hierl, Kristie Clarkin, et al.
Molecular Therapy. Nucleic Acids|April 21, 2025
Splicing correction by peptide-conjugated morpholinos as a novel treatment for late-onset Pompe diseaseRyan A Oliver, Meghan E Ahern, Perla G Castaneda, et al.
Pageof 8